# LifeMD, Inc.: Form 10-Q/A for the period ended Mar 31, 2018

- Company: [LifeMD, Inc.](/companies/lfmd.md) (CIK 948320)
- Form: 10-Q/A
- Filed: 2018-06-27
- Accepted by EDGAR: Jun 27, 2018, 16:16 ET
- Period: 2018-03-31
- Accession: 0001213900-18-008337
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/948320/000121390018008337/f10q0318a1_converisonlabs.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/948320/000121390018008337/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2018-01-01 to 2018-03-31 | $1.6m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2018-01-01 to 2018-03-31 | $355.5k | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2018-01-01 to 2018-03-31 | $1.3m | us-gaap:GrossProfit |
| Operating income | 3 months, 2018-01-01 to 2018-03-31 | −$279.3k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2018-01-01 to 2018-03-31 | $6.5k | us-gaap:InterestExpense |
| Net income | 3 months, 2018-01-01 to 2018-03-31 | $627.3k | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months, 2018-01-01 to 2018-03-31 | 46,239,430 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2018-01-01 to 2018-03-31 | $65.9k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2018-03-31 | $229.8k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $1.2m | us-gaap:AssetsCurrent |
| Current liabilities | at 2018-03-31 | $318.4k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2018-03-31 | $1.1m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/948320/000121390018008337/f10q0318a1_converisonlabs.htm

Filed Jun 27, 2018.
Source: SEC EDGAR, the filing index for accession 0001213900-18-008337. Last ingested by Listed: Nov 13, 2026, 16:33 ET. No prices; not investment advice.
